The activities of paraoxonase, xanthine oxidase, adenosine deaminase and the level of nitrite in pseudoexfoliation syndrome

Ophthalmic Research

Volumn 42, Issue 3, 2009, Pages 155-159

  Yaǧci, Ramazan ^a   Gürel, Ahmet ^c   Ersöz, Brahim I ^b   Karadaǧ, Remzi ^a   Hepşen, Ibrahim F ^a   Duman, Sunay ^b  

^a FATIH UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Nitric oxide; Paraoxonase; Pseudoexfoliation; Xanthine oxidase

Indexed keywords

ADENOSINE DEAMINASE; ARYLDIALKYLPHOSPHATASE; NITRITE; XANTHINE OXIDASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXFOLIATION SYNDROME; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOEXFOLIATION SYNDROME;

ADENOSINE DEAMINASE; AGED; ARYLDIALKYLPHOSPHATASE; EXFOLIATION SYNDROME; HUMANS; MIDDLE AGED; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; PURINES; SPECTROPHOTOMETRY; XANTHINE OXIDASE;

EID: 67651002476     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229306     Document Type: Article

References (39)

1. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA: Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992 ; 110: 1757-1762.
2. Ritch R, Schlötzer-Schrehardt U: Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265-315. (Pubitemid 32146432)
3. Naumann GO, Schlötzer-Schrehardt U, Kuchle M: Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology 1998 ; 105: 951-968.
4. Yaǧci R, Gürel A, Ersöz I, Keskin UC, Hepen IF, Duman S, Yiǧitoǧlu R: Oxidative stress and protein oxidation in pseudoexfoliation syndrome. Curr Eye Res 2006; 31: 1029-1032.
5. Ucakhan OO, Karel F, Kanpolat A, Devrim E, Durak I: Superoxide dismutase activity in the lens capsule of patients with pseudoexfoliation syndrome and cataract. J Cataract Refract Surg 2006; 32: 618-622.
6. Yimaz A, Adiguzel U, Tamer L, Yildirim O, Oz O, Vatansever H, Ercan B, Degirmenci US, Atik U: Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Exp Ophthalmol 2005 ; 33: 63-66.
7. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Bufidis T, Georgiadis N, Ringvold A: Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 2002; 134: 879-883.
8. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, Ritch R: 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87: 353-356.
9. Harman D: Free radical involvement in aging: Pathophysiology and therapeutic implications. Drugs Aging 1993; 3: 60-80.
10. Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115-134.
11. Spector A: Oxidative stress-induced cataract: mechanism of action. Faseb J 1995; 9: 1173-1182.
12. La Du BN: Structural and functional diversity of paraoxonases. Nat Med 1996; 2: 1186-1187.
13. Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M: Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br J Ophthalmol 2004; 88: 1256-1258.
14. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B: Human serum paraoxonase (PON 1) is inactivated by oxidized low-density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999; 26: 892-904.
15. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D, Muhtaroglu S: Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005; 38: 951-955.
16. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M: Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med 2003; 34 : 774-784.
17. Uz E, Oktem F, Yilmaz HR, Uzar E, Ozgüner F: The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: Protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2005; 277: 165-170.
18. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E: Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001; 21: 105-128.
19. Winn HR, Rubio R, Berne RM: Brain adenosine production in the rat during 60 seconds of ischemia. Circ Res 1979; 45: 486-492.
20. Schiavon R, De Fanti E, Giavarina D, Biasioli S, Cavalcanti G, Guidi G: Serum paraoxonase activity is decreased in uremic patients. Clin Chim Acta 1996; 247: 71-80.
21. Ilhan A, Yilmaz HR, Armutcu F, Gurel A, Akyol O: The protective effect of nebivolol on ischemia/reperfusion injury in rabbit spinal cord. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1153-1160.
22. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
23. Prajda N, Weber G: Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 1975 ; 59: 245-249.
24. Giusti G: Adenosine deaminase; in Bergmeyer M (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, pp 1092-1098.
25. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER: Age-related changes in oxidized proteins. J Biol Chem 1987; 262: 5488-5491.
26. Adelman R, Saul RL, Ames BN: Oxidative damage to DNA: Relation to species metabolic rate and life span. Proc Natl Acad Sci USA 1988 ; 85: 2706-2708.
27. Baskol G, Baskol M, Yurci A, Ozbakir O, Yucesoy M: Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Cell Biochem Funct 2006; 24 : 283-286. (Pubitemid 43764465)
28. Baskol G, Karakucuk S, Oner AO, Baskol M, Kocer D, Mirza E, Ustdal M: Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration. Ophthalmic Res 2006; 220: 12-16.
29. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR: Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-iminoethyl)lysine. J Pharmacol Exp Ther 2000; 295: 417-422.
30. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M: Increased nitric oxide production in patients with Behcet's disease: is it a new activity marker? J Am Acad Dermatol 2002 ; 46: 50-54.
31. Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, Ozerol E: Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Oph 2003; 106: 129-136.
32. Altintas O, Maral H, Yüksel N, Karabas VL, Dillioǧlugil MO, Caǧlar Y: Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2005 ; 243: 677-683.
33. Bruns RF: Adenosine receptors: Roles and pharmacology. Ann N Y Acad Sci 1990; 603: 211-225; discussion 225-226.
34. Schlotzer-Schrehardt U, Zenkel M, Decking U, Haubs D, Kruse FE, Junemann A, Coca-Prados M, Naumann GO: Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci 2005; 46: 2023-2034.
35. Ramkumar V, Hallam DM, Nie Z: Adenosine, oxidative stress and cytoprotection. Jpn J Pharmacol 2001; 86: 265-274.
36. Roth S, Rosenbaum PS, Osinski J, Park SS, Toledano AY, Li B, Moshfeghi AA: Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats. Exp Eye Res 1997; 65: 771-779.
37. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O, Yumru M, Savas HA, Akyol O: Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007 ; 38: 247-252.
38. Karabulut AB, Kafkasli A, Burak F, Gozukara EM: Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 2005; 23: 279-283.
39. Oztürk HS, Karaayvaz M, Kacmaz M, Kavutcu M, Akgül H, Durak I: Activities of the enzymes participating in purine and freeradical metabolism in cancerous human colorectal tissues. Cancer Biochem Biophys 1998 ; 16: 157-168.